MiroBio: Gilead completes acquisition of MiroBio in $405m cash deal
The UK biotech is a spin-out of Oxford University focused on research into autoimmune diseases
Read full article »
MiroBio is an England-based biotechnology company that develops and commercializes novel therapeutics for the treatment of auto-immune diseases.
Read more